Apollo Hospitals Enterprise Limited · NSE:APOLLOHOSP
Apollo Hospitals Enterprise — Q2 FY2012 Earnings Presentation
21 slides from Apollo Hospitals Enterprise's earnings presentation, November 2011
Slide 1: Q2 FY 2012 Earnings Update
Q4 FY 2012 Earnings Update Q2 FY 2012 Earnings Update 1
Slide 2: Safe Harbour
Safe Harbour No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all events not current after the
Slide 3: Contents
Contents • Q2 Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational Performance - Hospitals • Operational Performance – Standalone Pharmacies • Update on Projects • Update on non-hospital JVs, Associates 3
Slide 4: Q2 Highlights – (1/2) Financial Performance
Q2 Highlights – (1/2) • Q2 FY12 Consolidated Revenues of Rs 7,848 mio (up 20.4% yoy) Financial Performance • Consolidated EBITDA of Rs 1,311 mio (up 18.6% yoy) • Consolidated EBITDA margin at 16.7% as compared to 17.0% in Q2 FY11 • Consolidated PAT of Rs 550 mio (up 6.8% yoy); 7.0% PAT margin vs. 7.
Slide 5: Q2 Highlights – (2/2) Medical Initiatives Accomplishments
Q2 Highlights – (2/2) Medical Initiatives • Introduced Robotics for High end surgeries for Cardiothoracic, Urology, Laparoscopy and & Gynecology. Plan to introduce Robotics in seven key locations to provide cutting edge Accomplishments clinical care and augment the Centers of Excellence delivery. •
Slide 6: Contents
Contents • Q2 Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational Performance - Hospitals • Operational Performance – Standalone Pharmacies • Update on Projects • Update on non-hospital JVs, Associates 6
Slide 7: Consolidated Financial Performance (Unaudited)
Consolidated Financial Performance (Unaudited) ` Mio Q2 FY 11 Q2 FY 12 yoy (% ) H1FY 11 H1FY 12 yoy (% ) Income from Operations 6,127 7,364 20.2% 11,687 14,151 21.1% Add: Share of JVs 391 484 23.7% 741 931 25.6% Total Revenues 6,518 7,848 20.4% 12,428 15,082 21.3% EBITDA 1,105 1,311 18.6% 2,091 2,50
Slide 8: Contents
Contents • Q2 Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational Performance - Hospitals • Operational Performance – Standalone Pharmacies • Update on Projects • Update on non-hospital JVs, Associates 8
Slide 9: Standalone Financial Performance – (1/2)
Standalone Financial Performance – (1/2) ` Mio Q2 FY 11 Q2 FY 12 yoy (%) H1 FY 11 H1 FY 12 yoy (%) Key Highlights Revenue 5,864 6,998 19.3% 11,097 13,408 20.8% • Revenues of Rs 13,408 mio, 20.8% yoy growth Operative Expenses (3,177) (3,762) 18.4% (6,032) (7,296) 21.0% Employee Expenses (909) (1,095)
Slide 10: Standalone Segment-wise Performance – (2/2)
Standalone Segment-wise Performance – (2/2) ` Mio Q2 FY 11 Q2 FY 12 yoy (%) H1 FY 11 H1 FY 12 yoy (%) Key Highlights Revenues from each segment • Healthcare services Heathcare Services * 4,204 4,915 16.9% 8,040 9,429 17.3% Revenues at Rs 9,429 Stand-alone Pharmacy 1,663 2,085 25.4% 3,059 3,982 30.2%
Slide 11: Contents
Contents • Q2 Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational Performance - Hospitals • Operational Performance – Standalone Pharmacies • Update on Projects • Update on non-hospital JVs, Associates 11
Slide 12: Operational Performance – Hospitals
Operational Performance – Hospitals ` Mio Total (5) Chennai cluster Hyderabad cluster Others (1) Significant subs/ JVs/ associates (2) Particulars H1FY11 H1FY12 Growth yoy H1FY11 H1FY12 Growth yoy H1FY11 H1FY12 Growth yoy H1FY11 H1FY12 Growth yoy H1FY11 H1FY12 Growth yoy (%) (%) (%) (%) (%) No. of O
Slide 13: Contents
Contents • Q2 Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational Performance - Hospitals • Operational Performance – Standalone Pharmacies • Update on Projects • Update on non-hospital JVs, Associates 13
Slide 14: Operational Performance – Standalone Pharmacies
Operational Performance – Standalone Pharmacies ` Mio Batch Particulars Q2 FY 11 Q2 FY 12 yoy % H1 FY 11 H1 FY 12 yoy % No of Stores 315 300 315 300 Upto FY 2007 Batch Revenue/store 2.12 2.37 11.7% 4.02 4.65 15.7% EBITDA /store 0.11 0.14 24.8% 0.20 0.26 28.6% EBITDA Margin % 5.3% 5.9% 61 bps 5.0% 5.
Slide 15: Contents
Contents • Q2 Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational Performance - Hospitals • Operational Performance – Standalone Pharmacies • Update on Projects • Update on non-hospital JVs, Associates 15
Slide 16: Key Hospital Expansion Plan & Update on Execution
Key Hospital Expansion Plan & Update on Execution Total Estim ated AHEL's Share Focus on owned hospitals Type of Project Cost of Cost Location CoD* Hospital No of Beds (Rs.m n) (Rs.m n) • No. of owned hospitals to increase to over 49 from Mumbai Cluster 37 Navi Mumbai FY14 Super Specialty 350 3,500
Slide 17: Contents
Contents • Q2 Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational Performance - Hospitals • Operational Performance - Standalone Pharmacies • Update on Projects • Update on non-hospital JVs, Associates 17
Slide 18: Update on non hospital JVs, Associates
Update on non hospital JVs, Associates ` Mio Particulars Q2 FY 11 Q2 FY 12 yoy % H1 FY 11 H1 FY 12 yoy % • Y-O-Y revenue growth of 10.2% • Expansion in EBITDA Total Income 1,131 1,220 7.9% 2,215 2,441 10.2% margins by 85 bps at 15.4% in H1FY12 as compared to 14.6% in EBITDA 176 184 4.6% 323 376 16.6
Slide 19: Q&A
Q&A 19
Slide 20: Appendix: Basis of Consolidation
Appendix: Basis of Consolidation AHEL Standalone Location Description Chennai Main Chennai Hospital ASH - Chennai Chennai Hospital Tondiarpet - Chennai Chennai Hospital FirstMed - Chennai Chennai Hospital Apollo Children's Hospital Chennai Hospital Madurai Madurai Hospital Karur Karur Hospital Karai
Slide 21: Hospitals – Understanding Key Operating Metrics
Hospitals – Understanding Key Operating Metrics Description Formula / Calculation Key Driver • Number of operating • - • Project execution Operating Beds beds • Capital Expenditure x • In-patient Bed Days • In-patient Bed Days • Brand Outpatient Occupancy Visits Billed • Doctor reputation • Quality
Apollo Hospitals Enterprise — Q2 FY2012 Earnings Presentation on 6ix